Cost of Cervical Cancer Screening in Developing Countries
Author Information
Author(s): Jeremy D Goldhaber-Fiebert, Sue J Goldie
Primary Institution: Harvard School of Public Health
Hypothesis
What are the costs associated with cervical cancer screening in five developing countries?
Conclusion
Cost estimates of laboratory processing, sample transport, and patient time account for a significant proportion of total cervical cancer screening costs in five developing countries.
Supporting Evidence
- Cost estimates for cervical cancer screening vary significantly across countries.
- Laboratory processing and patient time are major contributors to overall screening costs.
- Different screening methods have varying cost implications based on local resources.
Takeaway
This study looks at how much it costs to screen for cervical cancer in five countries, showing that things like lab work and patient travel can add up to a lot.
Methodology
The study used cost-effectiveness analysis to estimate costs associated with cervical cancer screening, including direct medical and non-medical costs.
Potential Biases
Potential bias due to reliance on expert opinion rather than direct observation of costs.
Limitations
Estimates rely on expert opinion and may not reflect actual costs in each country; assumptions about technology and local market prices may affect accuracy.
Participant Demographics
The study focused on women eligible for cervical cancer screening in India, Kenya, Peru, South Africa, and Thailand.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website